Liquid Phase Peptide Synthesis Market Players:
- ©AAPPTec.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- CEM Corporation
- Bachem AG
- CSBio
- Biotage
- AnaSpec
- ZenBio, Inc
- Thermo Fisher Scientific Inc.
- GenScript
- PolyPeptide Group
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of liquid phase peptide synthesis is assessed at USD 6.5 billion.
The global liquid phase peptide synthesis market size surpassed USD 5.96 billion in 2025 and is projected to witness a CAGR of over 10.1%, crossing USD 15.6 billion revenue by 2035.
North America is projected to command a 42% revenue share by 2035 in the liquid phase peptide synthesis market, attributable to robust research and development investments and extensive peptide utilization in drug discovery and development.
Key players in the market include E Way Technology Co. Ltd., Nanoinnova Technologies SL, Graphenea Inc., Global Graphene Group, Cheap Tubes, Inc., BGT Material Limited, ACS Materials, LLC, Garmor Inc., CVD Equipment Corporation, Applynano Solutions S. L., Avanzare Innovacion Technologica S.L.
